The human papillomavirus type 16 E5 (HPV16-E5) protein is a membrane protein that has been associated with malignant growth. The protein aects growth factor-mediated signal transduction in a ligand-dependent manner. We show now that E5 expression in A31 ®broblasts results in an increased level of diacylglycerol (DAG) and inositol phosphates. Immunoprecipitation of phospholipase C-g-1 (PLC-g-1) with speci®c antibodies and immunoblotting with anti-phosphotyrosine antibodies reveal a large increase in tyrosine phosphorylation of the enzyme in E5-expressing cells compared to control vector-transfected cells. This activation of tyrosine phosphorylation is growth factor independent. In addition, an enhanced formation of phosphatidic acid (PA) was observed in E5 cells. This increase did not result from activation of phospholipase D (PLD), although the enzyme was activatable by treatment with phorbol ester. Thus, a phosphohydrolase-mediated DAG synthesis from PLD-produced PA can be excluded. The observed eects were not further enhanced by EGF showing that the presence of the growth factor is not necessary for maintaining permanent activation of PLC-g-1 in E5-expressing cells. The DAG-and inositol phosphatemediated signal cascade within the cells is thus eectively uncoupled from external control via EGF and its receptor in the presence of E5 protein.
Introduction
Human papillomaviruses of the`high risk type' have been associated with malignant growth in epithelial cells (zur Hausen, 1989 (zur Hausen, , 1991 . Two of the virusencoded proteins, E6 and E7, seem to be responsible for the oncogenic properties of the virus. Recently another viral protein, E5, has also been associated with malignant growth (Leptak et al., 1991; Leechanachai et al., 1992; Pim et al., 1992; Bouvard et al., 1994) . In addition, this protein seems to cooperate with E7 in the transformation of primary cells (Faulkner-Valle and Banks, 1995) . HPV type 16 (HPV16)-E5 is an 83 residue protein, strongly hydrophobic and is associated with cellular membranes (Conrad et al., 1993; Auvinen et al., 1997) . The diculty of producing antibodies to this protein has strongly hampered E5 research, but using fusion proteins it has become possible to localize the protein as mainly associated with the Golgi apparatus, the endosomes and, to a slight extent, with the plasma membrane (Conrad et al., 1993, and our unpublished results) . The function of E5 is unknown. The only known eects of E5 seem to rely on an enhancement of growth-factor-mediated signal transduction as well as on altering the gap-junctionmediated cell-cell communication (Straight et al., 1993; Crusius et al., 1997; Oelze et al., 1995) . It has been shown that in A31 ®broblasts permanently transfected with E5, the activation of the EGF receptor as well as MAP kinase (erk1/2) activation are strongly increased, resulting in an altered cellular growth . In addition, it has been reported that E5 may interact with the 16 kD subunit of the membrane-bound proton ATPase, resulting in increased recycling of the EGF receptor to the plasma membrane (Straight et al., 1993; Faulkner-Valle and Banks, 1995) . Also interesting is the fact that E5-expression is accompanied by an increased translocation of phorbol 12-myristate 13-acetate (PMA)-dependent PKC subtypes to the cellular membranes (Crusius et al., , 1998 . Transcription/translation of the E5 reading frame in the presence of microsomal membranes results in the incorporation of the protein into the added membranes (Faulkner-Valle and Banks, 1995; Faccini et al., 1996) . Thus many of the functions of E5 may be due to its localization in cellular membranes.
In the last years increasing evidence has been presented showing the key role of phospholipases in signaling events (Dicheva and Irvine, 1995) . Many of the enzymatic products generated by breaking down membrane phospholipids have been found to possess signaling properties and to function as second messengers (Nishizuka, 1992; Lambeth and Ryu, 1996; Liscovitch, 1996) . Further, a direct relationship between tyrosine protein kinases and phospholipases has been found, pointing to the phospholipases as key enzymes in signal transduction (Lambeth and Ryu, 1996) . Three main groups of phospholipases have been investigated in recent times: (i) Phospholipases C (PLC), known to degrade phosphatidylinositol-4,5-bisphosphate (PIP 2 ) resulting in the formation of diacylglycerol (DAG) and inositol trisphosphate (IP 3 ) as ®nal products, and thereby activating protein kinase C (PKC) and calcium metabolism, respectively (Hokin, 1985) ; (ii) The gap of phospholipases D (PLD), responsible mainly for enzymatic degradation of phosphatidylcholine, and also producing DAG by an indirect mechanism, upon conversion of phosphatidic acid (PA) by a phosphohydrolase (Kobayashi and Kanfer, 1987) ; and (iii) Finally the phospholipases A 2 (PLA 2 ), comprising the cytoplasmic form of the PLA 2 (cPLA 2 ), responsible for the metabolism of arachidonic acid and the formation of hydroxyeicosatetraenoic acids (HETEs) and prostaglandins. No information exists concerning the eect of HPV16 E5-expression on the activity of these dierent phospholipases. This would be of de®nite interest in the light of the eects of E5 on EGFR activation and on membrane translocation of PMA-responsive PKCs as already demonstrated (Crusius et al., 1998) .
In this study we show that in contrast to control cells, E5-expressing cells contain constitutively activated PLC-g-1 accompanied by an enhanced DAG and IP formation. Thus, HPV16 E5 is able to modulate membrane signaling phospholipids in an EGF-independent manner.
Results
It has been shown that E5 expression in A31 cells potentiates the EGF-receptor-mediated signaling cascade, resulting in activation of the MAP kinases erk1/2 in a ligand-dependent manner (Leechanachai et al., 1992; Pim et al., 1992; Crusius et al., 1997) . Since HPV16 E5 is highly hydrophobic and is known to be localized in membranes (Conrad et al., 1993) , the question arose whether it might have an in¯uence on lipid signaling mechanisms involved in EGF-mediated signal transduction. EGF is known to stimulate phosphatidylinositol turnover by activating PLC-g-1 via the EGF-receptor resulting in the formation of DAG and inositol triphosphate (IP 3 ) (Wahl and Carpenter, 1988) .
In order to study the eect of HPV16 E5 on the phosphatidylinositol turnover, we analysed the formation of DAG in untreated and EGF-treated E5-and Neo-cells after radioactive prelabeling of phospholipids with arachidonic acid.
The data in Table 1 show that E5-expressing cells contained twice as much DAG as the basal DAG levels measured in Neo-cells. EGF-treatment had no further stimulatory eect on DAG formation in both cell types. These results indicate (i) that E5 expression triggers an enhanced formation of DAG and (ii) that this increase is independent of EGF.
Next we analysed the content of inositol phosphates as the second product of PLC-g-1. E5-and Neo-cells were prelabeled for 24 h with 3 H-myo-inositol and then treated for 5 min in the absence or presence of EGF.
As shown in Table 1 , E5-cells displayed an enhanced formation of inositolphosphates as compared to the basal levels measured in Neo-cells, similar to DAG formation. This eect was not further increased by EGF treatment in either cell type.
The data obtained for DAG and inositolphosphates suggest that expression of HPV16 E5 in A31-cells resulted in a drastically enhanced phosphatidylinositol turnover, which seems to be independent of EGFreceptor activation. Similar results were obtained using the human keratinocyte cell line HaCaT permanently expressing the HPV16 E5 gene (Oelze et al., 1995) . Also here we observed a 2 ± 3 times increased amount of IPs in E5-expressing cells compared to controls, and this increase was EGF-independent (results not shown).
Analysis of the [1-
14
C]-arachidonic acid-labeled phosphatidylinositol showed that there were no dierences in the labeled pool available as substrate for the PLC-g-1 (our unpublished results). To further substantiate these results, we determined the absolute amounts of PI in E5-and Neo-cells by measuring the phosphorous content of separated PI. We found a phosphatidylinositol level of 16 nmoles/ng protein for the E5 cells and of 18 nmoles/mg protein for control cells. These results therefore demonstrate that the dierences in IPs and DAG formation are not based on a larger content of total phosphatidylinositol or of its radioactively labeled precursors in E5 cells.
In several cell systems increased DAG synthesis resulted in translocation and activation of DAGkinase, which phosphorylates DAG to form PA. Therefore we analysed whether, analogous to DAG, the formation of PA was also altered in cells expressing the E5 gene. As shown in Table 1 , E5-expressing cells contained up to 75% more phosphatidic acid than control-transfected cells. As in the case of DAG formation, an EGF-treatment of both cell systems did not result in a further increase of PA.
DAG may also be an indirect product of a PLDcatalyzed reaction (formation of PA and subsequent conversion to DAG by a phosphohydrolase (Kobayashi and Kanfer, 1987) . Therefore we next asked if this increase in PA was due to the action of a PLD. We examined the activity of PLD by inducing the transphosphatidylation reaction, which is performed exclusively by this enzyme (Kobayashi and Kanfer, 1987) . Cells were incubated in the presence of 0.3% butanol to measure phosphatidylbutanol as a relatively stable endproduct of PLD. By this method only very small amounts of phosphatidylbutanol were detected in E5-or Neo-cells, suggesting that PLD cannot be responsible for the increased formation of DAG observed in our cells. Further, no increased activation of PLD was observed in E5-or Neo-cells upon EGF treatment.
However, a PLD-mediated phosphatidylbutanol formation could be detected after stimulation of both cell types with PMA, a potent activator of this enzyme in several cell systems (Kaszkin et al., 1996; Schmidt et H-myoinositol (4 mCi/ml) and an additional hour with 1 mM LiCl. After medium change cells were treated with EGF or vehicle for 5 min. Extraction of labeled inositol phosphates was performed as described in Materials and methods. Each value represents the means+s.e. of three individual experiments and each experiment was repeated at least twice Kiss et al., 1998) , indicating that PLD can in principle be activated in these cells (data not shown).
These data indicate that PIP 2 -speci®c PLC-g-1 seems to be the phospholipase chie¯y responsible for the increased DAG formation observed in E5-expressing cells.
Activation of PLC-g-1 is thought to occur by binding of the enzyme via SH2 domains to phosphotyrosine of the EGF-receptor and subsequent phosphorylation by the EGF-receptor tyrosine kinase. However, activation by non-receptor tyrosine kinases has also been described (Katan, 1996) . Therefore we considered whether E5-cells show an increased basal PLC-g-1 activation by analysing the phosphorylation state of this enzyme compared to Neo-cells. PLC-g-1 was immunoprecipitated with speci®c antibodies and then tyrosine phosphorylation of the protein was detected by Western blot analysis. The results in Figure 1 show that tyrosine phosphorylation of PLCg-1 was clearly enhanced in E5 cells compared to Neocells. This dierence was not the result of an increased amount of enzyme, since immunoblotting of the stripped blot with antibodies to the enzyme showed only small dierences in the total amount of enzyme between the two cell types (Figure 1, lower panels) . This indicates that the PLC-g-1 is already activated in E5-expressing cells thereby resulting in the increased basal levels of DAG and IP observed in our experiments.
DAG and IP 3 are important second messengers for translocation and activation of the Ca 2+ -and phospholipid-dependent isoenzymes of the PKCfamily, i.e. PKC-a, -b and -g. The increase of lipid metabolites in E5-cells observed in this study implies an enhanced basal activation of one or more of these PKC-isoenzymes. Therefore we investigated the translocation of dierent PKC-isoenzymes to the particulate fraction of unstimulated E5-and Neo-cells. Translocation has been used as a measure of PKC activation. As shown in Figure 2 , E5 cells contain larger amounts of PKC-a and PKC-g in the particulate fraction than the corresponding controls (Figure 2, upper panels) , although the total amount of lipid-and Ca 2+ -dependent PKCs is rather similar in both cell types (Figure 2 , lower panels). Interestingly, A31 cells appear to be de®cient in PKC-b, since only very small amounts of the enzyme were found in the E5-and none in Neo-cells (Figure 2, lower panels) . Interestingly, A31 cells appear to be de®cient in PKC-b, since only very small amounts of the enzyme were found in the E5-and none in Neo-cells (Figure 2, lower panels) . We therefore postulated that the enhanced DAG and IP formation might be involved in the enhanced translocation (and therefore activation) to the membranes of the Ca 2+ -and lipid-dependent PKCisoenzymes a and g in E5 cells.
Discussion
It has been shown that the human papillomavirus type 16 E5 protein enhances EGF receptor activation in a ligand-dependent manner (Straight et al., 1993; Crusius et al., 1997) . In addition, in several cell systems it has been shown that activation of PLC and PLD is modulated by the EGF receptor and that some types of PKC may control PLD activity (Exton, 1998; Wahl and Carpenter, 1988; Kaszkin et al., 1992; Yeo and Exton, 1995) . Further, an increase in the activity of lipid-dependent PKC-isoenzymes in E5-expressing cells has been observed (Straight et al., 1993) . Therefore, a potential mechanism could be envisaged by which E5 Figure 1 Phosphorylation of PLC-g-1. E5-and Neo-cells were incubated for 24 h in DMEM with 0.2% BSA and then protein extracts were prepared in RIPA buer. 750 mg of protein were immunoprecipitated with anti-PLC-g-1, and the precipitate was separated on acrylamide gels. Western blotting was performed using the anti-phosphotyrosine antibody. After stripping, the blot was reacted with the same PLC-g-1 antibody used for immunoprecipitation, to account for the total amount of enzyme. Reactions were developed using the ECL method Figure 2 Translocation of PKC isotypes to the membrane fraction of E5 cells. Cells were disrupted by incubation in hypotonic lysis buer and homogenization in a Dounce homogenizer. The homogenates were centrifuged at 1000 g to separate undisrupted cells, and the supernatants were centrifuged at 100 000 g for 40 min. The sediment was denatured with SDS and b-mercapthoethanol and separated by acrylamide gel electrophoresis. Immunoblots were prepared and reacted with antibodies speci®c for the dierent PKC isotypes (upper panel). A total cellular extract of E5 and Neo cells was prepared in SDS/bmercapthoethanol and the proteins were separated by acrylamide gel electrophoresis. Immunoblots were prepared and reacted with the same antibodies described before. Reactions were developed with the ECL method (lower panel). Each experiment was performed three times with similar results modi®es the cellular lipid metabolism and modulates activity of some lipid-dependent enzymes.
In the present study we have presented data demonstrating that the formation of DAG and IP is strongly enhanced in E5-expressing compared to control-transfected cells. This enhancement is probably due to the increased activation of a PIP 2 -speci®c PLC, since the total amounts of phosphatidylinositol in the membranes of E5-and Neo-cells are very similar, making it very unlikely that the increased amounts of IPs and DAG found in E5-cells are the result of a higher concentration of substrate for the PLC. In addition, it is very improbable that PLD was involved in the increased amount of DAG observed through a phosphohydrolase (see Results). These results suggest therefore that the PA amount observed in E5-cells was due to the activity of a diacylglycerol kinase, which after translocation to the membranes can rapidly metabolize DAG to PA (for a review, see Sakane and Kanoh, 1997) . Thus it appears very likely that HPV16 E5 does not modulate PLD activity in A31 cells and that the increase in DAG and inositol phosphates was exclusively due to the increased activity of the PIP 2 -speci®c PLC.
As shown in our results, treatment of the cells with EGF had no further stimulatory eects on the synthesis of DAG or IPs in both E5-and Neo-cells. This suggests an uncoupling between activation of the EGF receptor and phosphorylation (and subsequent activation) of PLC-g-1. Interestingly, an enhanced constitutive activity of PLC-g-1 has also been described in several tumors, suggesting that it is a process associated with increased, uncontrolled proliferation (Homma et al., 1996; Rahimi et al., 1996) . The fact that only PLC and not PLD is modulated by E5 suggests that this modulation is a very speci®c one.
A question emerging from these experiments is the mechanism by which E5 modulates activation of PLCg-1. Since our results show that in our cells PLC-g-1 is insensitive to EGF treatment, other mechanisms must be responsible for the permanent activation found in E5 cells. In this context it should be mentioned that in several cell systems, src-kinase can also be involved in the activation of PLC-g-1 activity (Khare et al., 1997; Reynolds et al., 1993; Singer et al., 1997) . At this stage, however, whether this enhanced activation is the result of increased phosphorylation in an E5-dependent manner or an impaired PLC-g-1-speci®c phosphatase remains to be demonstrated.
Another possibility for the dierences in activation found is to postulate that PLC-g-1 activation takes place by translocation to cellular membranes, in a manner similar to PKCs. Since E5 is a membrane protein it may be that changes in the lipid composition of the membranes produced by its incorporation increase PLC translocation and therefore activation. A similar mechanism could also be responsible for the increased PKC translocation shown in our experiments. Finally, the eect of E5 may be a dual one, increasing PLC phosphorylation through an EGFRindependent pathway and altering the lipid composition of the cellular membranes. Determining which, if any, of these potential mechanisms is actually functionning must be our next priority.
In summary, our results show that HPV16 E5 expression leads to increased production of DAG and IPs and eectively uncouples this internal signal cascade from extracellular control through EGF and its receptor. Further experiments concerning membrane composition and phospholipid turnover of cells transfected with mutants of the E5-protein should help to elucidate the function of this viral protein in eukaryotic cell systems.
Materials and methods
Cell and cell culture A31-E5 and A31-Neo mouse ®broblasts (E5 and Neo cells, respectively) have already been described (Leechanachai et al., 1992) . Cells were grown in DMEM with 10% FCS. Treatments were performed as described in the corresponding Figure legends .
Determination of inositol phosphates, DAG, and PA Inositol phosphates were determined by labeling the cells over 24 h with 3 H-myo-inositol (speci®c activity 20 mCi/mmol) in the absence of FCS and with 0.2% fatty acid-free BSA. One hour prior to addition of ligands, cells were incubated in culture medium containing 1 mM LiCl in order to avoid degradation of inositol phosphates by phosphatases. After incubation for the indicated periods the medium was removed, 1 ml of cold trichoroacetic acid was added and the cells were scraped into a siliconized reagent glass. After 20 min incubation on ice, proteins were separated by centrifugation and the supernatant was extracted ®ve times with water-saturated diethylether and neutralized with 1 M KHCO 3 . Inositol phosphates were separated on SAX 100 mg columns. After equilibration in KHCO 3 and water, the probes were added to the column, washed and total inositol phosphates were eluted with 0.25 M KHCO 3 . Radioactivity was counted in a liquid scintillation counter.
To calculate DAG content, cells were plated on 3 cm dishes and grown until 80% con¯uency. After starvation for 24 h, 0.4 mCi/dish of [1-14 C]-arachidonic acid (speci®c activity 50 mCi/mmol) was added and cells were incubated overnight. After medium change and treatment with ligands, lipids were isolated by chloroform/methanol extraction according to Bligh and Dyer (1959) and DAG was measured using thin layer chromatography and benzene/chloroform/methanol (80 : 15 : 5 by vol.) As running system. 1,2-dioleylglycerol was used as standard. PA was extracted using the same procedure and the upper phase of ethylacetate/isooctane/ acetic acid/water (130 : 20 : 30 : 100 by volume) as a running system.
Quantitative analysis of the phosphatidylinositol-content of E5-and Neo-cells
In order to quantify phosphatidylinositol, its phosphorous content was determined after converting it to inorganic phosphate (Wagner et al., 1962) . Brie¯y, lipid extracts of E5-and Neo-cells were separated by t.l.c. in the solvent system consisting of chloroform ± methanol-acetic acid ± water (65 : 45 : 3 : 1 by vol.). Then the plates were developed in iodine vapour, and the spots corresponding to phosphatidylinositol were scraped o the plates and transferred to phosphate-free glass tubes. Lipids were digested by adding 500 ml of perchloric acid (60%) to each tube and incubating for 2 h at 1808C. To each sample 5 ml of a mixture of ascorbic acid (10%), ammonium molybdate (2.5%) and perchloric acid (5%) were added, and the probes were incubated for a further 2 h at 378C in a water bath shaker. In parallel a standard phosphate solution of Na 2 HPO 4 (0.1 ± 1 mmol/ml) was also incubated. The blue colour developed was read at 660 nm against a blank prepared under identical conditions. The mmoles of phosphatidylinositol were calculated directly from the standard curve and were related to 1 mg protein.
Phospholipases D activity
For determination of the PLD activity, cells were labeled with 3 H-myristic acid (speci®c activity 40 Ci/mmol) for 16 h, starved, and incubated in the presence of 0.2% fatty acid-free BSA. 0.3% butanol was added for the last ten incubation minutes. Cells were washed with PBS and then taken into 1.5 ml of ice-cold methanol and mixed with 750 ml water and 500 ml chloroform. After addition of 750 ml 0.2 N HCl, 1 ml chloroform and 20 mg of phosphatidylbutanol as standard, the extracts were mixed, incubated for 15 min at RT and the two phases were separated by centrifugation. The lower phase was carefully recovered and an aliquot was used to measure the total amount of radioactivity. The rest was taken up in chloroform-methanol (2 : 1) and separated on this layer chromatography. Phosphatidylbutanol spots were revealed with iodine, scraped into a vial, scintillation liquid was added, and radioactivity was measured in a scintillation counter.
Western blot analysis of phospholipase C-g-1
To determine the activation state of the PLC-g-1 as indicated by the degree of tyrosine phosphorylation, E5 and Neo cells were grown until 80% con¯uency and then starved for 20 h. A protein extract was prepared in RIPA buer and 750 mg of protein was used for immunoprecipitation using antibodies to PLC-g-1 and protein A-Sepharose. The sediment was taken in 1% SDS, electrophoresed on 7% acrylamide gels and immunoblotted using phosphotyrosine speci®c antibodies (Transduction Laboratories, Hamburg, Germany). Detection was done with the ECL system (Amersham-Pharmacia, Freiburg, Germany).
Protein kinase C analysis
Membrane and cytosolic fractions were isolated from E5-and Neo-cells as described earlier (Crusius et al., 1998) . Proteins were denatured with SDS/b-mercaptoethanol and immunoblotted as described using speci®c antibodies against the dierent PKC isoenzymes (Transduction Laboratories).
